Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2388-2407.e9
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 33
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 31
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 28
Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy
Mengdi Guo, M. Liu, David G. Brooks
Trends in Immunology (2024) Vol. 45, Iss. 4, pp. 303-313
Closed Access | Times Cited: 20
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 17
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Michael T. Lotze, Scott H. Olejniczak, Dimitris Skokos
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 878-895
Closed Access | Times Cited: 15
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies
Haolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117252-117252
Open Access | Times Cited: 11
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, et al.
Science Immunology (2024) Vol. 9, Iss. 97
Closed Access | Times Cited: 9
A CAR enhancer increases the activity and persistence of CAR T cells
Taha Rakhshandehroo, Shreya R. Mantri, Seyed Heydar Moravej, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 9
SMAD4 Regulates the Expression of LCK Affecting Chimeric Antigen Receptor‐T Cells Proliferation Through PI3K/Akt Signaling Pathway
Rongxue Wan, Bowen Fu, Xuemei Fu, et al.
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Open Access | Times Cited: 1
Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy
Bohan Zhang, Jiawen Wu, Hua Jiang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 320-320
Open Access | Times Cited: 1
Adoptive T cell therapy for ovarian cancer
Sarah B. Gitto, Chibuike Ihewulezi, Daniel J. Powell
Gynecologic Oncology (2024) Vol. 186, pp. 77-84
Closed Access | Times Cited: 8
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Advances in reprogramming of energy metabolism in tumor T cells
Liu Xuekai, Yan Song, Jian Chu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
CAR-T cell combination therapies in hematologic malignancies
Delian Zhou, Xiaojian Zhu, Yi Xiao
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL
Lars Fabian Prinz, Tobias Riët, Daniel Felix Neureuther, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101421-101421
Open Access | Times Cited: 6
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
Zachary Walsh, Parin Shah, Neeharika Kothapalli, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 6
Altered cancer metabolism and implications for next-generation CAR T-cell therapies
Rishab Ramapriyan, Vivasvan S. Vykunta, Gust Vandecandelaere, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108667-108667
Closed Access | Times Cited: 4
Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
Kimberly Veliz, Feng Shen, Olga Shestova, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200819-200819
Open Access | Times Cited: 4
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
Arne Van der Vreken, Karin Vanderkerken, Elke De Bruyne, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors
Martina Spiga, Elisa Martini, Maria Chiara Maffia, et al.
Seminars in Immunopathology (2024) Vol. 46, Iss. 3-4
Closed Access | Times Cited: 4
Non-viral vectors for chimeric antigen receptor immunotherapy
Sandy Tretbar, Joel G. Rurik, Even H Rustad, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top